Week in Washington 020824

Week in Washington is brought to you by Michael Cohen, PhD. Tune in each week to read the latest on healthcare policy and get a glimpse of what’s on the horizon.

Week in Washington

02/08/2024

Congress

  • The chances of changes to doctor payments, whether increases in Medicare payment rates or site neutral payment reform, appear to be dimming in the near term. Axios reported that site neutral payment reform is particularly unlikely to happen.
  • Congress currently is focused on international issues and will soon pivot to avoiding a government shutdown.

Florida Challenge

The State of Florida is suing CMS to overturn a regulation that requires states to remain eligible for Medicaid/CHIP for 12 straight months. Florida is not only pushing for the ability to disenroll children within 12 months but also stop CMS from preventing other states from rapidly disenrolling children.

J&J Lawsuit

A class action lawsuit against Johnson and Johnson was filed this week. The suit claims that J&J mismanaged its employees’ prescription drug benefits program resulting in employees being over charged for prescription drugs. If successful, it could spawn other lawsuits against drug makers/PBMs.

Advanced Notice Reaction

Multiple large Medicare Advantage companies expressed concerns over the proposed cut in base payments in the Advanced Notice. CVS and Centene announce they would need to adjust their plans to account for the lower rates.

Previous editions: 

02/01/2024: Week in Washington

01/26/2024: Week in Washington

01/18/2024: Week in Washington

01/11/2024: Week in Washington

 

01/04/2024: Week in Washington

12/14/2023: Week in Washington

12/07/2023: Week in Washington

11/30/2023: Week in Washington

Read More Wakely Insights
©2017-2024 Wakely Consulting Group LLC  All Rights Reserved. The materials in this document represent the opinion of the authors and are not representative of the views of Wakely Consulting Group. Wakely does not certify the information, nor does it guarantee the accuracy and completeness of such information. Use of this information is voluntary.